President Donald J. Trump issued an executive order to address the high cost of prescription drugs in the United States.

The order mandates that the government secure the lowest prices paid by other developed nations for pharmaceuticals.

To achieve this, it instructs various federal agencies—including the Secretaries of Commerce and Health and Human Services—to utilize a multi-pronged approach involving negotiations, potential rulemaking, and legal action against anti-competitive practices.

Failure by pharmaceutical companies to comply with the new pricing goals could trigger stricter regulatory measures, including direct-to-consumer sales facilitation at the most-favored-nation price and the possible certification to Congress for importation of lower-cost drugs from other developed countries.

The order also addresses potential legal and budgetary challenges related to its implementation.

This executive order aims to curb overcriminalization in federal regulations.

It addresses concerns about the excessive number and complexity of regulations, many carrying potential criminal penalties, by requiring agencies to review and report on existing criminal regulatory offenses, clarifying mens rea requirements in future rulemaking, and establishing guidelines for agency referrals to the Department of Justice for potential criminal prosecution.

Exemptions exist for immigration laws and national security matters.

President Trump issued an executive order aiming to bolster domestic pharmaceutical production by streamlining relevant regulations.

The order directs the FDA, EPA, and the Army Corps of Engineers to review and reduce bureaucratic hurdles for new and expanding pharmaceutical manufacturing facilities.

This also includes measures to improve the inspection of foreign pharmaceutical manufacturing facilities and coordinate environmental permits.

The goal is to increase both the speed and domestic capacity of pharmaceutical product creation, enhance national security, and improve medicine affordability.

President Donald J. Trump's proclamation declares May 4-10, 2025, as National Small Business Week.

The proclamation emphasizes the vital contribution of small businesses to the U.S. economy, job creation, and innovation.

While acknowledging recent challenges faced by small businesses, it highlights the administration's efforts to address issues like unfair trade practices and burdensome regulations through initiatives such as the Made in America Manufacturing Initiative. The proclamation serves as a recognition of small business owners and entrepreneurs.

This Presidential order addresses the overlapping tariffs on specific imported articles previously imposed under different statutory authorities.

It establishes a non-stacking procedure to ensure that tariff rates remain at levels necessary to meet their intended policy goals.

The order outlines which tariffs take precedence in cases of overlap and clarifies that this does not invalidate the earlier individual actions, while also addressing implementation mechanisms and setting deadlines for changes to guidance and systems.

President Trump issued a proclamation amending prior proclamations that imposed tariffs on imported automobiles and auto parts.

The amendments modify the tariff system by offering U.S. automobile manufacturers an import adjustment offset amount based on the number of vehicles assembled domestically, thereby incentivizing increased domestic production and reducing reliance on foreign-made components.

This is justified to enhance national security and support the domestic automotive industry.

President Donald J. Trump's proclamation designates April 26, 2025, as World Intellectual Property Day.

The proclamation emphasizes the crucial role of intellectual property in American innovation and economic prosperity, highlighting the administration's efforts to protect American inventions and creations, both domestically and internationally.

This includes actions like promoting trade deals that secure better intellectual property protections and using tariffs to deter theft.

The proclamation underscores the historical significance of intellectual property rights entrenched in the US Constitution and the importance of continued technological leadership for the nation's future.

This executive order establishes a US policy to accelerate responsible development of seabed mineral resources, citing national security and economic interests in securing critical minerals independent of foreign adversaries.

The order directs several federal agencies to streamline permitting processes, increase investment in deep-sea technologies, and engage in international partnerships to develop domestic supply chains and counter China's influence in the sector.

It also mandates reporting on various aspects of seabed mineral resource development, including assessments of environmental impacts, economic feasibility, and international cooperation.